Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
09:47am, Thursday, 16'th May 2024
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
11:51am, Wednesday, 15'th May 2024
QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.
As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is approved for diagnostic use // Regulatory framework
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
11:11am, Tuesday, 14'th May 2024
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
QIAGEN (QGEN) to Enhance Forensics With New Partnership
01:26pm, Monday, 13'th May 2024
QIAGEN's (QGEN) recent deal advances a novel test for its QIAcuity digital PCR devices. This will enhance forensics by improving the quantification of DNA in human samples.
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
02:00am, Monday, 13'th May 2024
QIAstat-Dx Respiratory Panel Plus designed for accurate diagnosis of respiratory infections, enabling detection of co-infections // Panel generates results in about one hour with less than one minute
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
04:05pm, Tuesday, 07'th May 2024
Collaboration aims to create novel digital PCR assay to improve successful results in DNA analysis from human samples for use in forensics and human identification // DNA quantification enables law en
International Markets and Qiagen (QGEN): A Deep Dive for Investors
09:56am, Monday, 06'th May 2024
Review Qiagen's (QGEN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
04:05pm, Thursday, 02'nd May 2024
QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data // New software advances p
Qiagen N.V. (QGEN) Q1 2024 Earnings Call Transcript
03:27pm, Tuesday, 30'th Apr 2024
Qiagen N.V. (NYSE:QGEN ) Q1 2024 Earnings Conference Call April 30, 2024 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - Chief Executive Officer Rola
QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
01:31pm, Tuesday, 30'th Apr 2024
QIAGEN (QGEN) Q1 results are driven by solid growth in consumables and ongoing higher instruments placements.
Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings
07:31pm, Monday, 29'th Apr 2024
While the top- and bottom-line numbers for Qiagen (QGEN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to
Qiagen (QGEN) Surpasses Q1 Earnings and Revenue Estimates
06:26pm, Monday, 29'th Apr 2024
Qiagen (QGEN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.53 per share a year ago.
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
04:05pm, Monday, 29'th Apr 2024
Q1 2024: Net sales of $459 million (-5% actual rates, -5% constant exchange rates, CER); diluted EPS of $0.36 and adjusted diluted EPS of $0.46 // Net sales at CER of $462 million ahead of outlook for
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
04:05pm, Wednesday, 24'th Apr 2024
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and
